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Abstract
Background:  Bilateral emphysematous pyelonephritis is a life threatening condition usually
occurring in diabetics. Management of this condition has traditionally been aggressive and surgery
is considered mandatory. However, this is itself a hazardous intervention in a septic, unstable
patient with circulatory or liver failure. When bilateral disease is present, the need for long-term
dialysis is obviously unavoidable.
Case presentation: We herein report one of the few cases of bilateral emphysematous
pyelonephritis successfully managed by non-surgical treatment.
Background
Emphysematous pyelonephritis (EPN) is a rare, life-
threatening condition, usually occurring in diabetic pa-
tients [1]. Patients with emphysematous pyelonephritis
are typically very ill with circulatory/liver failure caused by
sepsis. In most cases, a normal native kidney is involved
unilaterally, but in 10% of cases, the condition is bilateral
[2]. Management of this condition has traditionally been
aggressive and surgery has been considered mandatory.
Many of the earlier series have stressed the very high mor-
tality rate (75%) and the need for urgent nephrectomy [3–
6]. However, this is itself a hazardous intervention in a
septic patient with unstable circulatory or liver failure. In
the case of bilateral renal disease, the patient requires
long-term dialysis. With the advent of CT scanning, more
powerful antibiotics, and better access to life support, an
alternative medical approach to radical surgery has
emerged [7].
Here we report one of the few cases of bilateral empyse-
matous pyelonephritis successfully managed by non-sur-
gical treatment.
Case report
A 41-year-old non-insulin dependent diabetic female
with transverse myelitis was referred after a 7-day history
of fever, generalized malaise, vomiting, increasing breath-
lessness and oliguria. She was a type 2 diabetic (onset 14
year before), requiring insulin for glucose control. She
had been treated with high dose of steroids for transverse
myelitis.
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Upon admission, the patient appeared confused and ob-
tunded, was febrile (39.0 C), tachycardic (110 beats/min)
and hypotensive (90/60 mm Hg). She was conscious but
not completely oriented in time and space. Cardiac and
respiratory examinations were unremarkable.
Relevant laboratory data were as follows: glucose 31.5
mmol/L, urea of 89 mmol/L, creatinine of 168 µmol/L,
sodium of 133 mmol/L, and potassium of 5.2 mmol/L.
Her hemoglobin was 7.7 g/dL, hematocrit 24 %, total pe-
ripheral white cell count of 17700 with a shift to the left,
and a platelet count of 20 000 (Table 1). Arterial blood
gases showed high anion gap metabolic acidosis. Initial
ultrasound showed bilateral enlarged edematous kidneys.
An abdominal computed tomography (CT) scan showed
diffusely enlarged kidneys, with perinephric edema, ex-
tensive gas in the renal tissues and perinephric areas bilat-
erally (Figure 1). She was treated with intravenous fluids,
ceftriaxone and amikacin.
Because of persistent high fever, hypotension, an increase
in the total peripheral white cell count and worsening re-
nal function (Table 1) the patient was transferred to the
intensive care unit on day two and was treated with intra-
venous fluids, a tritrated insulin infusion, ceftriaxone,
amikacin and inotropic support with dopamine. On re-
view by the urologists, it was thought that conservative
management should be attempted given the absence of
obstruction of the urinary tract. Blood and urine cultures
grew Escherichia Coli senstive to amikacin and ceftiraxone
as well as ciprofloxacin.
The patient' s clinical condition improved remarkably
over the fourth day of treatment, thus obviating the need
for surgery.
A Follow-up CT scan obtained 7 days after the initial study
showed global improvement with marked reduction of
the gas within the kidneys and a decrease in perinephric
edema.
Two weeks after admission to the hospital, during which
time she made a steady clinical recovery, her antibiotic
was switched to oral ciprofloxacin and fluconazole and
was sent home 15 days after admission with a serum cre-
atinine concentration of 124 µmol/L (Table 1). A CT scan
on discharge showed complete resolution of the renal em-
physema.
Upon further review she is clinically well and free of infec-
tion.
Conclusions
First described in 1898, emphysematous pyelonephritis
(EPN) is an acute necrotizing parenchymal and perirenal
infection caused by gas forming uropathogens [8–10].
Four factors appear to be involved in the pathogenesis of
EPN: gas-forming bacteria, high tissue glucose, impaired
tissue perfusion and a defective immune response [11].
Diabetics account for 70–90% of all cases [9,12].
The organisms most commonly associated with EPN are
E. Coli, Klebsiella pneumoniae, Proteus mirabilis, Pseu-
domonas aeruginosa, Aerobacter aerogenes, Citrobacter
and rarely yeast. Left untreated, EPN is uniformly fatal
[13].
Estimates of mortality using current therapy range from
10% to 40% with patients treated medically having a
higher mortality than those treated surgically, 70% versus
30%, respectively [8,9,12,14]. Thus, traditionally, it is
Table 1: Laboratory Findings. Results of hematologic and blood chemical values.
Variable On Admission Second Day Fifteenth Day
Hematocrit (%) 28 25 38
White-cell count (per mm3) 17,200 25,000 5800
Differential count (%)
Neutrophils 85 90 65
Lymphocytes 15 10 35
Platelet count (per mm3) 20, 000 15,000 110,000
Glucose (mmol/L) 31.5 22.2 7.5
Blood urea nitrogen (mmol/L) 32 39 15
Creatinine (µmmol/L) 168 247 124
Sodium (mmol/L) 133 130 148
Potassium (mmol/L) 5.2 5.7 4.8
Chloride (mmol/L) 102 92 107
Carbon dioxide (mmol/L) 13.2 9.2 23.5BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/4
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thought that antibiotic therapy alone is usually ineffec-
tive, and prompt nephrectomy is necessary [12].
In a previous report of 48 cases of EPN patients were clas-
sified in four classes according to CT findings, from class
1(the mildest) to class 4 (the most severe form) [15].
Ninety-six per cent (96%) had diabetes mellitus with 22%
also having urinary obstruction. The mortality rate in
those receiving antibiotics alone was 40% (2 of 5). The
success rate of those treated with percutaneous catheter
drainage (PCD) plus antibiotics (27 of 41) was 66% and
those who had nephrectomy was 90% (9 of the 10 pa-
tients). In EPN class 1 and 2, all the patients who were
treated with PCD plus antibiotics survived. In extensive
EPN (classes 3 and 4), 85% (17 of 20) were successfully
treated with PCD and antibiotics. Eight of the 14 who had
an unsuccessful treatment using a PCD underwent ne-
phrectomy, seven of whom survived.
Hui reported a case of EPN treated with nephrectomy and
stated that based on available data, surgical intervention
appears to be the preferred treatment [16]. Chen et al de-
scribed 10-year experience with 25 EPN patients [17].
Eighty per cent (80%) required antibiotics plus PCD only;
12% underwent nephrectomy and 8% died. Shokeir re-
viewed their 15-year experience of 20 patients with EPN in
Egypt [18]. He emphasized that immediate nephrectomy,
as soon as the patient is medically stable, should not be
delayed.
Goldsmith [19], Kondo [20], Labussiere [21,22], Punnose
[22], Jain [23], and Best [24] all have described individual
cases of EPN treated successfully with antibiotics alone.
Angulo [25], Grozel [26], Shimizu [27] and Tahir [19]
et.al. Each reported cases of bilateral EPN that were suc-
cessfully treated with antibiotics alone, thus obviating the
need for renal replacement therapy which would have
Figure 1
An abdominal computed tomography scan showed diffusely enlarged kidneys, with perinephric edema, extensive gas in the
renal tissues and perinephric areas bilaterally.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/4
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been needed if they were treated with bilateral nephrecto-
mies.
We believe that nephrectomy is not the preferred treat-
ment anymore for all cases of emphysematous pyelone-
phritis. EPN shall be classified into grades of severity and
treatment planned accordingly. Although difficult to per-
form because of the rarity of EPN, randomized controlled
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